Urology devices market set to top $56 billion by 2030

The urology devices market is projected to rise from $40.39 billion in 2025 to $43.05 billion in 2026, according to The Business Research Company. Growth is being driven by more kidney and urinary tract disease, wider use of endoscopic procedures, and rising investment in robotic surgery and advanced diagnostics.

Why it matters: - The urology devices market is expanding as urinary tract and kidney-related disease becomes more common worldwide. - Higher demand for diagnostic and treatment tools affects hospitals, outpatient centers, and specialized urology care providers. - The market’s growth signals broader adoption of minimally invasive and technology-enabled procedures.

What happened: - The Business Research Company released its Urology Devices Global Market Report 2026, covering market size, trends, and a forecast through 2035. - The report estimates the market will grow from $40.39 billion in 2025 to $43.05 billion in 2026. - The report projects the market will reach $56.39 billion by 2030. - North America held the largest regional share of the global market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

The details: - The market’s 2025-2026 growth rate is projected at 6.6% CAGR. - The forecast period calls for 7.0% CAGR growth. - Historical growth is tied to higher rates of kidney and urinary tract diseases, growth in hospital-based urology departments, wider availability of endoscopic procedures, an aging population, and better access to specialized urology care. - Future growth is linked to investment in robotic surgery platforms, precision urological treatments, outpatient surgical centers, improved diagnostic accuracy, and advanced healthcare technologies. - The report highlights a free sample and a full report on the company’s website: Download a free sample and View the full report. - The report’s 2026 version adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - Rising rates of diabetes and obesity are adding to the burden of urologic disease, which increases demand for devices used to diagnose and treat these conditions. - NHS England reported 147,285 hospital admissions for primary urinary tract infection diagnoses in 2022-23. - People over 65 accounted for 56% of those admissions, or 82,392 cases, underscoring the impact of aging on urology demand. - The shift toward minimally invasive and robotic-assisted care suggests device makers are competing on precision, imaging integration, and procedural efficiency rather than volume alone. - North America’s lead points to mature healthcare infrastructure, while faster growth in emerging markets may come from expanding access to advanced technologies.

What's next: - Investment in robotic surgery platforms and outpatient surgical centers is expected to keep supporting market growth. - Broader adoption of advanced imaging and minimally invasive procedures should continue to shape product demand. - Emerging regions are likely to contribute more as healthcare systems expand and access to specialized care improves.

The bottom line: - Urology devices are moving from a steady-growth category to a technology-driven market with strong demand from aging populations and rising disease burden.